ArticleCureus2025
Challenges and Strategies for Successful Insulin Pump Therapy in an Elderly Patient With Type 1 Diabetes and Comorbidities: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Managing type 1 diabetes mellitus (T1DM) in elderly patients with multiple comorbidities presents significant challenges, particularly when complicated by persistent glycemic variability, severe hypoglycemia, and hypoglycemia unawareness. We present a 72-year-old Saudi male with T1DM, ischemic heart disease, hypertension, hypothyroidism, and peripheral neuropathy who was transitioned from multiple daily injections to insulin pump therapy. Prior to intervention, he had frequent severe hypoglycemia and elevated glycated hemoglobin (HbA1c) levels (9.4%, 8.8%). Following the initiation of hybrid closed-loop insulin pump therapy, glycemic control improved (HbA1c 7.7%), and hypoglycemia episodes decreased. However, a language barrier led to a critical insulin dosing error and hospitalization. This case highlights both the benefits and potential risks of insulin pump use in elderly patients. It underscores the importance of addressing language barriers, providing individualized education, and involving caregivers to reduce adverse outcomes. The case adds to the limited data on advanced diabetes technology in the elderly with complex comorbidities. Insulin pump therapy can be effective in elderly patients with T1DM and multiple comorbidities when personalized support and appropriate safeguards are implemented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.